Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen
Public ClinicalTrials.gov record NCT00135369. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Study Switching HIV-1 Infected Subjects With an Undetectable Viral Load From a HAART Regimen Dosed Twice Daily or More Frequently to a Once-Daily HAART Regimen
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate that virologically controlled HIV-infected individuals can successfully switch from a standard-of-care regimen dosed twice-daily or more frequently to a simpler once-daily (QD) regimen while maintaining virologic control, as evaluated by the proportion of subjects who continue to have plasma HIV-1 levels \<50 copies/mL after switching to a QD regimen.
Study identification
- NCT ID
- NCT00135369
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2002 (Type not available)
- Primary completion
- Jul 2005 (Actual)
- Completion
- Jul 2005 (Actual)
- Last update posted
- Apr 25, 2011
2002 – 2005
United States locations
- U.S. sites
- 46
- U.S. states
- 24
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Hobson City | Alabama | — | — |
| Local Institution | Montgomery | Alabama | — | — |
| Local Institution | Phoenix | Arizona | — | — |
| Local Institution | Little Rock | Arkansas | — | — |
| Local Institution | Los Angeles | California | — | — |
| Local Institution | Sacramento | California | — | — |
| Local Institution | San Mateo | California | — | — |
| Local Institution | Torrance | California | — | — |
| Local Institution | Denver | Colorado | — | — |
| Local Institution | Norwalk | Connecticut | — | — |
| Local Institution | Stratford | Connecticut | — | — |
| Local Institution | Washington D.C. | District of Columbia | — | — |
| Local Institution | Fort Lauderdale | Florida | — | — |
| Local Institution | Miami | Florida | — | — |
| Local Institution | Miami Beach | Florida | — | — |
| Local Institution | Pensacola | Florida | — | — |
| Local Institution | Tampa | Florida | — | — |
| Local Institution | Decatur | Georgia | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Indianapolis | Indiana | — | — |
| Local Institution | New Orleans | Louisiana | — | — |
| Local Institution | Baltimore | Maryland | — | — |
| Local Institution | Boston | Massachusetts | — | — |
| Local Institution | Berkley | Michigan | — | — |
| Local Institution | Detroit | Michigan | — | — |
| Local Institution | St Louis | Missouri | — | — |
| Local Institution | Las Vegas | Nevada | — | — |
| Local Institution | Hackensack | New Jersey | — | — |
| Local Institution | Jersey City | New Jersey | — | — |
| Local Institution | Neptune City | New Jersey | — | — |
| Local Institution | Somers Point | New Jersey | — | — |
| Local Institution | Manhasset | New York | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | The Bronx | New York | — | — |
| Local Institution | Charlotte | North Carolina | — | — |
| Local Institution | Huntersville | North Carolina | — | — |
| Local Institution | Washington | North Carolina | — | — |
| Local Institution | Winston-Salem | North Carolina | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Reading | Pennsylvania | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | Galveston | Texas | — | — |
| Local Institution | Houston | Texas | — | — |
| Local Institution | Annandale | Virginia | — | — |
| Local Institution | Hampton | Virginia | — | — |
| Local Institution | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00135369, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 25, 2011 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00135369 live on ClinicalTrials.gov.